PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2DX22F3PTT4556730209!dupixent 300 MG 2 ML syringe 2ml

The incumbent holds $19.3B across 1,357,999 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award under parent SPE2DX15D3005. PoP ended Mar 30, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Dla Troop Support

Awarding office

Mar 30, 2022

PoP end

$121K

Obligated

$121K

Potential

325411

NAICS

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position — $90

Contract facts

Federal

Contract numberSPE2DX22F3PTT

Also listed asSPE2DX15D3005-SPE2DX22F3PTT

AgencyDla Troop Support

Awarding officeDla Troop Support

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

CAGE1XUY5

UEIKABZK8W6PQT3

NAICS325411

No full NAICS 325411 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDVSPE2DX15D3005

Place of performanceCONSHOHOCKEN PA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startMar 29, 2022

PoP end (current)Mar 30, 2022

Obligated$121K

Current value$121K

Potential value$121K

4556730209!DUPIXENT 300 MG/2 ML SYRINGE 2ML is a federal award for Dla Troop Support. Estimated value $121K ($121K obligated). Current period of performance ends Mar 30, 2022. Place of performance: CONSHOHOCKEN PA.

4556730209!DUPIXENT 300 MG/2 ML SYRINGE 2ML

Recompete timing

Public

● Past PoP end (1605 days ago)

Current PoP ended Mar 30, 2022 (1605 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Incumbent — $19.3B obligated across 1,357,999 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($19.3B) · all agencies

Department of Defense (DOD)$19.3B · 100%Department of Health and Human Services (HHS)$7.6M · 0%Department of Veterans Affairs (VA)$5.9M · 0%Department of Justice (DOJ)$68K · 0%

Related awards

Same parent · incumbent

36C77026P0121

DROSPIRENONE

$321K

Sep 27, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract SPE2DX22F3PTT?

SPE2DX22F3PTT (4556730209!dupixent 300 MG 2 ML syringe 2ml) is a Dla Troop Support award with a potential value of $121K. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded SPE2DX22F3PTT?

Dla Troop Support awarded SPE2DX22F3PTT (potential $121K).

When does SPE2DX22F3PTT come up for recompete?

SCOUT tracks a period-of-performance end of Mar 30, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 11, 2026 · refreshed monthlyLatest procurement action Mar 29, 2022